Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • wangli
    Member
    • Apr 2012
    • 48

    gene ID type

    Dear All

    I am using DAVID to do the pathway and GO analysis. My selected differentially expressed gene IDs are as follows: POPTR_0002s23610, PopTR_0014s19710, which are from the Populus trichocarpa genome v2.0 on Phytozyme website.
    The DAVID software supplies a list of types of gene ID, such as:
    Gene ID Type Supported in DAVID
    AFFY_ID
    ENSEMBL
    ENTREZ_GENE_ID
    FLYBASE_ID
    GENBANK_ACCESSION
    GENEBANK_ID
    GENPEPT_ACCESSION
    HAMAP_ID
    HSSP_ID
    Illumina
    NOT SURE
    OFFICIAL_GENE_SYMBOL
    PIR_ACCESSION
    PIR_ID
    PIR_NREF_ID
    REFSEQ_GENOMIC
    REFSEQ_MRNA
    REFSEQ_PROTEIN
    REFSEQ_RNA
    RGD_ID
    TIGR_ID
    UNIGENE
    UNIPROT_ACCESSION
    UNIPROT_ID
    UNIREF100_ID
    WORMBASE_ID

    I tried to choose NOTSURE, but it didnot help to find the right gene ID type.

    Is anyone familiar with the geneID type I provided? I will appreciate any comments.

    Li

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
15 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
15 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
37 views
0 reactions
Last Post SEQadmin2  
Working...